EXPO EXPONENT, INC.
Research report · from SEC EDGAR · close 2026-07-13
$63.59 +2.4%
$3.08B mkt cap
executive summary
EXPONENT, INC. (EXPO) is a $3.08B company. Revenue is $582.0M (+4.2% y/y) at a 18% net margin. It is profitable. Our health score is B (70/100). 1 red flag on file. Held by 1 tracked funds. It funds itself; low dilution risk.
Revenue (FY)
$582.0M
+4.2% y/y
⚠One-sided insider selling
7 insider sales and no open-market buys in the recent window.
who's buying
Insider buys / sells
0 / 7
Cash & ST investments
$118.6M
Operating cash flow
$131.7M
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.